دورية أكاديمية

Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial

التفاصيل البيبلوغرافية
العنوان: Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial
المؤلفون: Rausa, Marialuisa, PALOMBA, DANIELA, Cevoli, Sabina, Lazzerini, Luana, Sancisi, Elisa, Cortelli, Pietro, Pierangeli, Giulia
المساهمون: Rausa, Marialuisa, Palomba, Daniela, Cevoli, Sabina, Lazzerini, Luana, Sancisi, Elisa, Cortelli, Pietro, Pierangeli, Giulia
بيانات النشر: Springer-Verlag Italia s.r.l.
سنة النشر: 2016
المجموعة: Padua Research Archive (IRIS - Università degli Studi di Padova)
مصطلحات موضوعية: Biofeedback, Chronic migraine, Coping strategie, Medication overuse headache, Preventive therapy, Psychological treatment, Adult, Analgesic, Combined Modality Therapy, Female, Headache Disorders, Secondary, Human, Male, Middle Aged, Neurofeedback, Pilot Project, Single-Blind Method, Outcome Assessment (Health Care), Neurology (clinical), Anesthesiology and Pain Medicine
الوصف: Background: Medication overuse headache (MOH) is a major clinical concern and a common health risk. Recent literature stressed the need to manage chronic headache by using integrated biobehavioral approaches. Few studies evaluated how biofeedback can be useful in MOH. The aim of the study is to evaluate in a randomized, controlled, single-blind trial the effects of biofeedback associated with traditional pharmacological therapy in the prophylactic treatment of MOH. Method: Twenty-seven subjects were randomized to frontal electromyographic (EMG) biofeedback associated with prophylactic pharmacological therapy (Bfb Group) or to pharmacological treatment alone (Control Group). The primary outcome was to evaluate the number of patients that return episodic after treatment. Secondly we evaluate the effects of frontal EMG BFB on frequency of headache and analgesic intake. Changes in coping strategies and in EMG frontalis tension were also evaluated. ANOVA was performed on all the variables of interest. Results: Our results indicate that at the end of treatment the number of patients that returned episodic in the Bfb group was significantly higher than in the Control group. Patients in the Bfb group differed from the Control group in headache frequency, amount of drug intake and active coping with pain. These outcomes were confirmed also after 4 months of follow-up. No significant effects were observed in EMG recordings. Conclusions: Biofeedback added to traditional pharmacological therapy in the treatment of MOH is a promising approach for reducing headache frequency and analgesic intake. Modification of coping cognitions in the Bfb group, as an adjunct mechanism of self-regulation, needs more evaluations to understand the role of biofeedback in changing maladaptive psychophysiological responses.
نوع الوثيقة: article in journal/newspaper
وصف الملف: STAMPA
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27655371; info:eu-repo/semantics/altIdentifier/wos/WOS:000386612100001; volume:17; issue:1; firstpage:87; lastpage:94; numberofpages:8; journal:THE JOURNAL OF HEADACHE AND PAIN; http://hdl.handle.net/11577/3218671Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84988664186; link.springer.de/link/service/journals/10194/index.htm
DOI: 10.1186/s10194-016-0679-9
الإتاحة: https://doi.org/10.1186/s10194-016-0679-9Test
http://hdl.handle.net/11577/3218671Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.8AC4C308
قاعدة البيانات: BASE